These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25749563)

  • 1. Prevalence of phylogroups and O25/ST131 in susceptible and extended-spectrum β-lactamase-producing Escherichia coli isolates, the Netherlands.
    Overdevest IT; Bergmans AM; Verweij JJ; Vissers J; Bax N; Snelders E; Kluytmans JA
    Clin Microbiol Infect; 2015 Jun; 21(6):570.e1-4. PubMed ID: 25749563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014.
    Overdevest I; Haverkate M; Veenemans J; Hendriks Y; Verhulst C; Mulders A; Couprie W; Bootsma M; Johnson J; Kluytmans J
    Euro Surveill; 2016 Oct; 21(42):. PubMed ID: 27784530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
    Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
    J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of new variants of ST131 clonal group among extraintestinal pathogenic Escherichia coli producing extended-spectrum β-lactamases.
    Dahbi G; Mora A; López C; Alonso MP; Mamani R; Marzoa J; Coira A; García-Garrote F; Pita JM; Velasco D; Herrera A; Viso S; Blanco JE; Blanco M; Blanco J
    Int J Antimicrob Agents; 2013 Oct; 42(4):347-51. PubMed ID: 23992646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
    Ha YE; Kang CI; Cha MK; Park SY; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2013 Nov; 42(5):403-9. PubMed ID: 24071027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of the epidemic multiresistant Escherichia coli ST131 clonal group among extended-spectrum beta-lactamase-producing E. coli isolates in Copenhagen, Denmark.
    Olesen B; Hansen DS; Nilsson F; Frimodt-Møller J; Leihof RF; Struve C; Scheutz F; Johnston B; Krogfelt KA; Johnson JR
    J Clin Microbiol; 2013 Jun; 51(6):1779-85. PubMed ID: 23554186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital.
    Lafolie J; Nicolas-Chanoine MH; Grenouillet F; Hocquet D; Bertrand X
    Int J Antimicrob Agents; 2014 Nov; 44(5):466-8. PubMed ID: 25241262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of human pandemic O25:H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals.
    Ewers C; Grobbel M; Stamm I; Kopp PA; Diehl I; Semmler T; Fruth A; Beutlich J; Guerra B; Wieler LH; Guenther S
    J Antimicrob Chemother; 2010 Apr; 65(4):651-60. PubMed ID: 20118165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.
    Oteo J; Diestra K; Juan C; Bautista V; Novais A; Pérez-Vázquez M; Moyá B; Miró E; Coque TM; Oliver A; Cantón R; Navarro F; Campos J;
    Int J Antimicrob Agents; 2009 Aug; 34(2):173-6. PubMed ID: 19464856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131.
    Oteo J; Cercenado E; Cuevas O; Bautista V; Delgado-Iribarren A; Orden B; Pérez-Vázquez M; García-Cobos S; Campos J
    Diagn Microbiol Infect Dis; 2010 Jul; 67(3):270-6. PubMed ID: 20462723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan.
    Yokota S; Sato T; Okubo T; Ohkoshi Y; Okabayashi T; Kuwahara O; Tamura Y; Fujii N
    Chemotherapy; 2012; 58(1):52-9. PubMed ID: 22343392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011.
    Brolund A; Edquist PJ; Mäkitalo B; Olsson-Liljequist B; Söderblom T; Wisell KT; Giske CG
    Clin Microbiol Infect; 2014 Jun; 20(6):O344-52. PubMed ID: 24118431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
    Cheng MF; Chen WL; Hung WY; Huang IF; Chiou YH; Chen YS; Lee SS; Hung CH; Wang JL
    Pediatr Infect Dis J; 2015 May; 34(5):469-75. PubMed ID: 25879646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
    Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
    Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
    Suzuki S; Shibata N; Yamane K; Wachino J; Ito K; Arakawa Y
    J Antimicrob Chemother; 2009 Jan; 63(1):72-9. PubMed ID: 19004839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence?
    Ewers C; Bethe A; Stamm I; Grobbel M; Kopp PA; Guerra B; Stubbe M; Doi Y; Zong Z; Kola A; Schaufler K; Semmler T; Fruth A; Wieler LH; Guenther S
    J Antimicrob Chemother; 2014 May; 69(5):1224-30. PubMed ID: 24398338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.